Tailoring adverse drug event surveillance to the paediatric inpatient

Quality and Safety in Health Care

Volumn 19, Issue 5, 2010, Pages

  Long, Andrea L ^a,b   Horvath, Monica M ^a   Cozart, Heidi ^a   Eckstrand, Julie ^a   Whitehurst, Julie ^a   Ferranti, Jeffrey ^a  

^a DUKE UNIVERSITY HEALTH SYSTEM   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CROSS-SECTIONAL STUDY; DRUG TOXICITY; HEALTH SURVEY; HOSPITAL; HUMAN; METHODOLOGY; RETROSPECTIVE STUDY; TEACHING HOSPITAL;

CROSS-SECTIONAL STUDIES; DRUG TOXICITY; HOSPITALS, PEDIATRIC; HOSPITALS, TEACHING; HUMANS; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES;

EID: 78249249580     PISSN: 14753898     EISSN: 14753901     Source Type: Journal    
DOI: 10.1136/qshc.2009.032680     Document Type: Article

References (22)

1. Council on Clinical Information Technology. Pediatric aspects of inpatient health information technology systems.Pediatrics 2008;122:e1287-96.
2. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients.JAMA 2001;285:2114-20.
3. Holdsworth MT, Fichtl RE, Behta M, et al. Incidence and impact of adverse drug events in pediatric inpatients.Arch Pediatr Adolesc Med 2003;157:60-5.
4. Takata GS, Mason W, Taketomo C, et al. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.Pediatrics 2008;121:e927-35.
5. Ferranti J, Horvath M, Cozart H, et al. Re-evaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.Pediatrics 2008;121:e1201-7.
6. Ferranti J, Horvath M, Cozart H, et al. A multifaceted approach to safety: the synergistic detection of adverse drug events in adult inpatients.J Patient Saf 2008;4:184-90.
7. Horvath M, Cozart H, Ahmad A, et al. Sharing adverse drug event data using business intelligence technology.J of Patient Saf 2009;5:35-41.
8. Classen DC, Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients.JAMA 1991;266:2847-51.
9. Jha AK, Kuperman GJ, Teich JM, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.J Am Med Inform Assoc 1998;5:305-14.
10. Kilbridge PM, Campbell UC, Cozart HB, et al. Automated surveillance for adverse drug events at a community hospital and an academic medical center.J Am Med Inform Assoc 2006;13:372-7.
11. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting.Ann Intern Med 2004;140:795-801.
12. Benn J, Koutantji M, Wallace L, et al. Feedback from incident reporting: information and action to improve patient safety.Qual Saf Health Care 2009;18:11-21.
13. Pronovost P, Holzmueller C, Young J, et al. Using incident reporting to improve patient safety: a conceptual model.J Patient Saf 2007;3:27-33.
14. Suresh G, Horbar JD, Plsek P, et al. Voluntary anonymous reporting of medical errors for neonatal intensive care.Pediatrics 2004;113:1609-18.
15. Burkoski V. Identifying risk: the limitations of incident reporting.Can Nurse 2007;103:12-14.
16. Shojania KG. The frustrating case of incident-reporting systems.Qual Saf Health Care 2008;17:400-2.
17. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.Pediatrics 2004;114:297-316.
18. Kilbridge PM, Alexander L, Ahmad A. Implementation of a system for computerized adverse drug event surveillance and intervention at an academic medical center.J Clin Outcomes Manag 2006;13:94-100.
19. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions.Clin Pharmacol Ther 1981;30:239-45. (Pubitemid 12149145)
20. Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.Diabetes Care 2005;28:1245-9.
21. Sharek PJ, Horbar JD, Mason W, et al. Adverse events in the neonatal intensive care unit: development, testing, and findings of an NICU-focused trigger tool to identify harm in North American NICUs.Pediatrics 2006;118:1332-40.
22. Kilbridge PM, Noirot LA, Reichley RM, et al. Computerized surveillance for adverse drug events in a pediatric hospital.J Am Med Inform Assoc 2009;16:607-12.